Jane Street
MRVI icon

Jane Street’s Maravai LifeSciences MRVI Stock Holding History

Jane Street’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.4K Buy
27,000
+16,300
+152% +$55.3K ﹤0.01% 10771
2025
Q4 		$34.8K Buy
+10,700
New +$36K ﹤0.01% 10610
2024
Q2 		– Sell
-13,300
Closed -$115K – 9901
2024
Q1 		$115K Buy
+13,300
New +$90K ﹤0.01% 8476
2023
Q3 		– Sell
-87,100
Closed -$1.08M – 9109
2023
Q2 		$1.08M Buy
+87,100
New +$1.18M ﹤0.01% 5078
2023
Q1 		– Sell
-28,500
Closed -$408K – 9590
2022
Q4 		$408K Sell
28,500
-2,200
-7% -$34.6K ﹤0.01% 6498
2022
Q3 		$784K Buy
+30,700
New +$770K ﹤0.01% 5870
2022
Q2 		– Sell
-12,600
Closed -$444K – 10434
2022
Q1 		$444K Sell
12,600
-9,400
-43% -$315K ﹤0.01% 7705
2021
Q4 		$922K Sell
22,000
-147,500
-87% -$5.97M ﹤0.01% 6058
2021
Q3 		$8.32M Buy
169,500
+163,000
+2,508% +$7.95M ﹤0.01% 2041
2021
Q2 		$271K Hold
6,500
– – ﹤0.01% 8331
2021
Q1 		$232K Buy
+6,500
New +$215K ﹤0.01% 8068

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's MRVI Position: Q1 2026 in Review

Jane Street increased its Maravai LifeSciences (MRVI) stake by 26% in Q1 2026, buying an estimated $1.16M and bringing the position to 1,636,145 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3638.

Jane Street first reported a position in MRVI in Q4 2020 and has held it in 20 quarters since. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Jane Street held 1,636,145 shares of Maravai LifeSciences worth $4.63M as of Q1 2026.
  • Jane Street bought 341,087 Maravai LifeSciences shares in Q1 2026, an estimated $1.16M.
  • Maravai LifeSciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3638 holding.
  • Jane Street first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 20 quarters since.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.